1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
11C-PE2I and 18F-Dopa PET for assessing progression rate in Parkinson's : A longitudinal study
(
- Contribution to journal › Article
- 2016
-
Mark
Aberrant nigral diffusion in Parkinson's disease : A longitudinal diffusion tensor imaging study
(
- Contribution to journal › Article
-
Mark
Increased serotonin-to-dopamine transporter ratios in Parkinson disease dyskinesias: a longitudinal study
(
- Contribution to conference › Abstract
-
Mark
Imaging nigrostriatal circuitry with 11C-PE2I PET and Neuromelanin-sensitive MR in Parkinson’s disease
(
- Contribution to conference › Abstract
- 2015
-
Mark
The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography study.
(
- Contribution to journal › Article
- 2014
-
Mark
Long-term clinical outcome of fetal cell transplantation for Parkinson disease : two case reports
(
- Contribution to journal › Article
- 2012
-
Mark
Clinical application of stem cell therapy in Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
Serotonin Neuron Loss and Nonmotor Symptoms Continue in Parkinson's Patients Treated with Dopamine Grafts
(
- Contribution to journal › Article
- 2011
-
Mark
Graft-Induced Dyskinesias in Parkinson's Disease: High Striatal Serotonin/Dopamine Transporter Ratio
(
- Contribution to journal › Article
- 2010
-
Mark
Serotonergic Neurons Mediate Dyskinesia Side Effects in Parkinson's Patients with Neural Transplants
(
- Contribution to journal › Article